Have You Read Our Recent Publications? Download Them Here
The Acorn Regulatory publications have been downloaded thousands of times by C-Suite executives and regulatory professionals all over the world. Our expert team has written on a diverse range of industry related issues. Topics explored in the whitepapers have subsequently...
Download the Acorn Regulatory Whitepapers
Since 2016, the Acorn Regulatory whitepapers on issues such as pharmacovigilance, wholesale distribution authorisations, and Brexit have been well received.
Most Read Acorn Regulatory Pharmaceutical Articles of 2017
Over the course of the past twelve months the Acorn Regulatory pharmaceutical division has worked on projects in more than 70 countries around the world. In that time they have also taken time out to write some very well received...
Acorn Regulatory NewsAcorn Regulatory's Top 100 ArticlesGemma RobinsonHow-To & ExplainersMarketing Authorisation HoldersPharmaceuticalRegulatory AffairsRegulatory Strategy
How To Develop A Regulatory Strategy: An Overview
The old adage ‘failing to plan is planning to fail’ could not be any truer when considering your regulatory strategy. A carefully crafted regulatory strategy is crucial when a pharmaceutical company wishes to market its medicinal product across regions subject...
NTK: Need To Know – 5 Pharmaceutical Articles You Must Read
We produce hundreds of thought leadership pharmaceutical articles on our site and in publications each year. Here are just 5 pharmaceutical related articles that you might have missed and that you should read.
Are You Ready for the Falsified Medicines Directive?
The Falsified Medicines Directive (FMD) was published in 2011 with the aim of preventing falsified medicines from entering the pharmaceutical supply chain in the European Economic Area. Conformity with the FMD will be required from February 9th, 2019 next.
Acorn Regulatory NewsAcorn Regulatory's Top 100 ArticlesGemma RobinsonHow-To & ExplainersPharmaceuticalPharmacovigilance
Simplified Adverse Event Reporting in Europe – Are You Prepared for the Switch Over?
Since the introduction of the pharmacovigilance legislation in 2010, a commitment to a simplified approach to adverse event reporting was introduced by the EMA (Articles 107(3) and 107a(4) of Directive 2001/83/EC). This approach would only apply however following an independent...
Virtual Wholesaling of Medicinal Products: 5 Things You Need To Know
In this article we look at the five things that you need to know when considering virtual wholesaling.
Most Read Pharmaceutical News Stories on AcornRegulatory.com in 2016
The team at Acorn Regulatory has been busy all year working with our global client base. Nevertheless, they have taken time to share their expertise on issues such as risk minimisation, the EU regulatory framework, the Periodic Safety Update Single Assessment...
Acorn Regulatory News Roundup December 2016
In Acorn Regulatory News for December 2016 we are looking back at five of the stories over the past month that have caught your attention on our website and through our social media channels.
By using this website, you agree to our
cookie policy.
Close